Bath & Body Works Reports First Quarter Results Exceeding Guidance and Progress Against the Consumer First Formula

Sales and profits are falling, but management is spinning a weak quarter as progress.

What the company is saying

Bath & Body Works, Inc. wants investors to believe that the business is stabilizing and on the cusp of a turnaround, despite declining sales and profits. The company claims it 'delivers Q1 net sales and adjusted earnings per share results above guidance,' though it does not disclose the actual guidance figures, making this assertion unverifiable. Management frames the quarter as a step forward, emphasizing that 'our efforts to strengthen our hero categories, modernize the brand, and expand our reach are beginning to resonate with consumers,' but provides no concrete data or examples to support this. The announcement highlights 'early proof points' and 'encouragement,' but these are qualitative and lack substantiation. The company is careful to reaffirm full-year guidance, which itself projects further declines, and stresses that the foundation being built will 'drive improved performance over time,' with meaningful impact not expected until late 2026 or 2027. The tone is neutral but leans optimistic, using language that suggests confidence in the long-term plan while acknowledging current results are 'below the standard our brand is capable of delivering.' The communication style is measured, with no overt hype, but it does bury the fact that both sales and adjusted earnings are expected to fall further this year. The CFO transition is presented as orderly, with Eva Boratto stepping down and Tom Javitch named interim CFO, but the search for a permanent replacement is ongoing, which introduces some uncertainty. CEO Daniel Heaf is named, but there is no evidence of outside institutional involvement or high-profile investor participation. Overall, the narrative fits a classic playbook: acknowledge short-term pain, promise long-term gain, and ask investors for patience while offering little in the way of hard evidence for a near-term turnaround.

What the data suggests

The disclosed numbers show a business in decline, with Q1 2026 net sales at $1,378 million, down 3% from $1,424 million in Q1 2025. Earnings per diluted share for the quarter were $0.90, but this figure is inflated by one-time items, including an $88 million pre-tax gain from litigation settlements and a $62 million tax benefit. Adjusted earnings per diluted share, which strip out these items, were just $0.32, well below the headline number and lower than last year's adjusted results. Operating income and net income both benefited from these non-recurring gains, masking underlying weakness. The company’s own guidance for full-year 2026 projects net sales to decline by 4.5% to 2.5% versus 2025, and adjusted earnings per diluted share to fall to $2.40–$2.65 from $3.21 in 2025—a clear deterioration. Q2 2026 guidance also anticipates further declines, with net sales expected to drop 5% to 3% and adjusted EPS to fall from $0.37 to $0.20–$0.25. The company expects to generate $600 million in free cash flow for the year, but this is not contextualized against prior years or capital needs. Financial disclosures are generally detailed, with both GAAP and adjusted figures, but the absence of prior guidance figures for Q1 makes it impossible to verify claims of 'beating guidance.' An independent analyst would conclude that the business is shrinking, profitability is under pressure, and management’s optimism is not matched by the numbers.

Analysis

The announcement uses positive language to frame results, emphasizing that Q1 net sales and adjusted EPS were 'above guidance,' but does not provide the actual guidance figures for verification. While some realised results are disclosed (e.g., Q1 net sales, EPS), the majority of key claims are forward-looking, including full-year and Q2 guidance, and aspirational statements about returning to 'sustainable, durable growth.' The narrative highlights 'early proof points' and 'encouragement,' but offers no specific evidence or metrics to support these qualitative claims. The guidance itself projects further declines in sales and adjusted EPS, indicating a deteriorating trend despite the positive tone. There is no indication of a large capital outlay or immediate capital-intensive projects, and the benefits discussed are expected within the next 6–24 months. The gap between narrative and evidence is moderate, with some inflation in the language used to describe future prospects.

Risk flags

• ●Operational risk is elevated due to the CFO transition, with Eva Boratto stepping down and an interim CFO in place while a permanent replacement is sought. Leadership instability at the finance function can disrupt execution and impair financial oversight.
• ●Financial risk is high, as both net sales and adjusted earnings per share are projected to decline further in 2026. The company’s own guidance anticipates a drop in adjusted EPS from $3.21 to as low as $2.40, signaling deteriorating profitability.
• ●Disclosure risk is present because the company claims to have exceeded Q1 guidance but does not provide the actual guidance figures, making it impossible for investors to independently verify this claim. This lack of transparency undermines management credibility.
• ●Pattern-based risk is evident in the reliance on qualitative, forward-looking statements about brand momentum and consumer resonance, without any supporting data or metrics. This suggests a pattern of narrative inflation to offset weak fundamentals.
• ●Timeline/execution risk is substantial, as management’s turnaround narrative is predicated on improvements that are not expected until late 2026 or 2027. Investors face a long wait with no guarantee of delivery, during which the business may continue to deteriorate.
• ●Balance sheet risk is notable, with long-term debt of $3,613 million and a total equity deficit of ($1,131 million) as of May 2, 2026. High leverage and negative equity constrain financial flexibility and increase vulnerability to shocks.
• ●Guidance risk is high, as the company’s own outlook projects further declines in both sales and earnings, yet management continues to frame the situation optimistically. This disconnect between narrative and numbers is a red flag.
• ●Geographic concentration risk exists, as the vast majority of company-operated stores are in the United States (1,810 out of 1,923), making the business highly exposed to U.S. consumer trends and economic conditions.

Bottom line

For investors, this announcement signals a business under pressure, with both sales and adjusted profits falling and no evidence of a near-term turnaround. Management’s narrative is more optimistic than the numbers justify, relying on vague claims of brand momentum and future improvement that are unsupported by disclosed data. The CFO transition adds uncertainty, and the absence of prior guidance figures for Q1 means headline claims of 'beating guidance' cannot be independently verified. There is no evidence of notable institutional investor involvement or external validation. To change this assessment, the company would need to provide specific, verifiable guidance figures, disclose concrete metrics showing real progress in key categories, and demonstrate stabilization or growth in sales and adjusted earnings. Key metrics to watch in the next reporting period include actual Q2 sales and adjusted EPS versus guidance, any updates on the CFO search, and evidence of cash flow generation relative to expectations. At present, the signal is weak and should be treated with caution—this is a situation to monitor, not to buy aggressively. The single most important takeaway is that Bath & Body Works is a shrinking business with management asking for patience, but offering little hard evidence that a turnaround is underway.

Announcement summary

Bath & Body Works, Inc. (NYSE: BBWI) reported first quarter 2026 results, delivering net sales and adjusted earnings per share above guidance. Net sales for Q1 2026 were $1,378 million, a 3% decrease from $1,424 million in Q1 2025. Earnings per diluted share were $0.90, with adjusted earnings per diluted share at $0.32. The company reaffirmed its full-year 2026 guidance, projecting net sales to decline 4.5% to 2.5% and earnings per diluted share between $3.00 and $3.25. Chief Financial Officer Eva Boratto will step down on June 12, with Tom Javitch appointed as Interim CFO and a search for a permanent replacement underway. The company expects to generate approximately $600 million in free cash flow for fiscal 2026 and provided guidance for Q2 2026 net sales and earnings per share. These results and leadership changes are significant as the company continues to execute its Consumer First Formula and aims to return to sustainable, durable growth.

Disagree with this article?